Cited by 477Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 149 of the 150 references it cites were found in a registry or an index.

The molecular bases of Alzheimer’s disease and other neurodegenerative disorders

Open access

Maccioni, Ricardo B, Muñoz, Juan P, Barbeito, Luis·2001·Archives of Medical Research

DOI 10.1016/s0188-4409(01)00316-2

Open this paper in CoChat — free account

Abstract

Alzheimer's disease, the cause of one of the most common types of dementia, is a brain disorder affecting the elderly and is characterized by the formation of two main protein aggregates: senile plaques and neurofibrillary tangles, which are involved in the process leading to progressive neuronal degeneration and death. Neurodegeneration in Alzheimer's disease is a pathologic condition of cells rather than an accelerated way of aging. The senile plaques are generated by a deposition in the human brain of fibrils of the beta-amyloid peptide (Abeta), a fragment derived from the proteolytic processing of the amyloid precursor protein (APP). Tau protein is the major component of paired helical filaments (PHFs), which form a compact filamentous network described as neurofibrillary tangles (NFTs). Experiments with hippocampal cells in culture have indicated a relationship between fibrillary amyloid and the cascade of molecular signals that trigger tau hyperphosphorylations. Two main protein kinases have been shown to be involved in anomalous tau phosphorylations: the cyclin-dependent kinase Cdk5 and glycogen synthase kinase GSK3beta. Cdk5 plays a critical role in brain development and is associated with neurogenesis as revealed by studies in brain cells in culture and neuroblastoma cells. Deregulation of this protein kinase as induced by extracellular amyloid loading results in tau hyperphosphorylations, thus triggering a sequence of molecular events that lead to neuronal degeneration. Inhibitors of Cdk5 and GSK3beta and antisense oligonucleotides exert protection against neuronal death. On the other hand, there is cumulative evidence from studies in cultured brain cells and on brains that oxidative stress constitutes a main factor in the modification of normal signaling pathways in neuronal cells, leading to biochemical and structural abnormalities and neurodegeneration as related to the pathogenesis of Alzheimer's disease. This review is focused on the main protein aggregates responsible for neuronal death in both sporadic and familial forms of Alzheimer's disease, as well as on the alterations in the normal signaling pathways of functional neurons directly involved in neurodegeneration. The analysis is extended to the action of neuroprotective factors including selective inhibitors of tau phosphorylating protein kinases, estrogens, and antioxidants among other molecules that apparently prevent neuronal degeneration.

Integrity signals

Registry

Crossref · 10.1016/s0188-4409(01)00316-2

Cites

149 of 149 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy‐Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,715
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
Coyle, J. T., & Puttfarcken, P. (1993) · Science · doi:10.1126/science.7901908 · Cited by 3,762
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436

Show all 150 references

Research works printed but not linked: 2

Catania, 2001, Expression and localization of cyclin-dependent kinase 5 in apoptotic human glioma cells, Neurooncology, 3, 89
Saez, 1990, Gap junctions, In Vitro Toxicol, 3, 69

Sorted by citations

Items 101–200 of 477

Recent advances in polysaccharides from edible and medicinal Polygonati rhizoma: From bench to market
He, Y., Chen, Z., Nie, X., Wang, D., Zhang, Q., Peng, T., Zhang, C., Wu, D., & Zhang, J. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.12.010 · Cited by 76
Mass spectrometric identification of citrullination sites and immunohistochemical detection of citrullinated glial fibrillary acidic protein in Alzheimer's disease brains
Ishigami, A., Masutomi, H., Handa, S., Nakamura, M., Nakaya, S., Uchida, Y., Saito, Y., Murayama, S., Jang, B., Jeon, Y., et al. (2015) · Journal of Neuroscience Research · doi:10.1002/jnr.23620 · Cited by 76
The Damage Signals Hypothesis of Alzheimer's Disease Pathogenesis
Fernández, J. A., Rojo, L. E., Kuljiš, R. O., & Maccioni, R. B. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14307 · Cited by 77
Cerebrospinal fluid tau, Aß, and phosphorylated tau protein for the diagnosis of Alzheimer's disease
Formichi, P., Battisti, C., Radi, E., & Federico, A. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20602 · Cited by 80
Role of the endocannabinoid system in Alzheimer's disease: New perspectives
Pazos, M. R., Núñez, E., Benito, C., Tolón, R. M., & Romero, J. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.03.026 · Cited by 75
Aβ25-35 Injection into the Temporal Cortex Induces Chronic Inflammation that Contributes to Neurodegeneration and Spatial Memory Impairment in Rats
Díaz, A., Limón, I. D., Chávez, R., Zenteno, E., & Guevara, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-111979 · Cited by 73
Identification of neuronal network properties from the spectral analysis of calcium imaging signals in neuronal cultures
Tibau, E., Valencia, M., & Soriano, J. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00199 · Cited by 72
The neuroprotective effect of two statins: simvastatin and pravastatin on a streptozotocin-induced model of Alzheimer’s disease in rats
Tramontina, A. C., Wartchow, K. M., Rodrigues, L., Biasibetti, R., Quincozes‐Santos, A., Bobermin, L. D., Tramontina, F. F., & Gonçalves, C. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0680-z · Cited by 72
An integrated study of the affinities of the Aβ16 peptide for Cu( i ) and Cu( ii ): implications for the catalytic production of reactive oxygen species
Young, T. R., Kirchner, A., Wedd, A. G., & Xiao, Z. (2014) · Metallomics · doi:10.1039/c4mt00001c · Cited by 74
Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities
Samidurai, A., Xi, L., Das, A., Iness, A. N., Vigneshwar, N., Li, P., Singla, D. K., Muniyan, S., Batra, S. K., & Kukreja, R. C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107858 · Cited by 71
Biomarkers in translational research of Alzheimer’s Disease
Tarawneh, R., & Holtzman, D. M. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.006 · Cited by 67
Cellular mechanism of U18666A-mediated apoptosis in cultured murine cortical neurons: Bridging Niemann–Pick disease type C and Alzheimer's disease
Koh, C. H. V., & Cheung, N. S. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.04.006 · Cited by 67
Screening for Alzheimer’s Disease Using Saliva: A New Approach Based on Machine Learning and Raman Hyperspectroscopy
Ralbovsky, N. M., Halámková, L., Wall, K. M., Anderson‐Hanley, C., & Lednev, I. K. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190675 · Cited by 67
Purpurin modulates Tau-derived VQIVYK fibrillization and ameliorates Alzheimer’s disease-like symptoms in animal model
Viswanathan, G. K., Shwartz, D., Losev, Y., Arad, E., Shemesh, C., Pichinuk, E., Engel, H., Raveh, A., Jelinek, R., Cooper, I., et al. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03312-0 · Cited by 67
Anomalously phosphorylated tau and Aβ fragments in the CSF correlates with cognitive impairment in MCI subjects
Maccioni, R. B., Manuel Lavados, M., Guillón, M., Mújica, C. L. D., BOSCH, R., FARIAS, G., & FUENTES, P. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.011 · Cited by 68
Role of some functional lipids in preventing diseases and promoting health
Alabdulkarim, B., Bakeet, Z. A. N., & Arzoo, S. (2012) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2012.03.001 · Cited by 71
Age- and gender-related oxidative status determined in healthy subjects by means of OXY-SCORE, a potential new comprehensive index
Veglia, F., Cighetti, G., Franceschi, M., Zingaro, L., Boccotti, L., Tremoli, E., & Cavalca, V. (2006) · Biomarkers · doi:10.1080/13547500600898623 · Cited by 66
Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons.
Saez, T. E., Pehar, M., Vargas, M. R., Barbeito, L., & Maccioni, R. B. (2004) · PubMed · Cited by 67
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
Do, K. V., Hjorth, E., Wang, Y., Jun, B., Kautzmann, M.-A. I., Ohshima, M., Eriksdotter, M., Schultzberg, M., & Bazan, N. G. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01216-5 · Cited by 67
Nuclear bodies in neurodegenerative disease
Woulfe, J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.05.005 · Cited by 65
Amyloid Beta Peptide-Induced Cerebral Neuronal Loss Is Mediated By Caspase-3 In Vivo
Takuma, H., Tomiyama, T., Kuida, K., & Mori, H. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.3.255 · Cited by 66
Epigenetic regulation of adult neural stem cells: implications for Alzheimer’s disease
Fitzsimons, C. P., van Bodegraven, E. J., Schouten, M., Lardenoije, R., Kompotis, K., Kenis, G., van den Hurk, M., Boks, M. P., Biojone, C., Joca, S. R. L., et al. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-25 · Cited by 67
Nitric oxide and peroxynitrite serum levels in Parkinson's disease: correlation of oxidative stress and the severity of the disease.
Kouti, L., Noroozıan, M., Akhondzadeh, S., Abdollahi, M. R., Javadi, M. R., Faramarzi, M. A., Mousavi, S., & Ghaeli, P. (2013) · PubMed · Cited by 63
Oxidative Stress and Amyloid Beta Toxicity in Alzheimer’s Disease: Intervention in a Complex Relationship by Antioxidants
Chakrabarti, S., Sinha, M., Thakurta, I. G., Banerjee, P., & Chattopadhyay, M. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990152 · Cited by 63
Chronic ghrelin administration restores hippocampal long‐term potentiation and ameliorates memory impairment in rat model of Alzheimer's disease
Eslami, M., Sadeghi, B., & Goshadrou, F. (2018) · Hippocampus · doi:10.1002/hipo.23002 · Cited by 62
Therapeutic effects of non-saponin fraction with rich polysaccharide from Korean red ginseng on aging and Alzheimer's disease
Shin, S. J., Nam, Y., Park, Y. H., Kim, M., Lee, E., Jeon, S. G., Bae, B.-S., Seo, J., Shim, S., Kim, J.-S., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.12.454 · Cited by 61
Tau Oligomers as Potential Targets for Alzheimer’s Diagnosis and Novel Drugs
Guzmán‐Martínez, L., Farias, G. A., & Maccioni, R. B. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00167 · Cited by 62
Role of Neuron and Glia in Alzheimer’s Disease and Associated Vascular Dysfunction
Bandyopadhyay, S. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.653334 · Cited by 64
Effects of a glycogen synthase kinase-3 inhibitor, lithium, in adenomatous polyposis coli mutant mice
Gould, T. D. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00096-3 · Cited by 59
Targeting Cdk5 Activity in Neuronal Degeneration and Regeneration
Kanungo, J., Zheng, Y., Amin, N. D., & Pant, H. C. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9410-6 · Cited by 60
Red wine micronutrients as protective agents in Alzheimer-like induced insult
Russo, A., Palumbo, M., Aliano, C., Lempereur, L., Scoto, G. M., & Renis, M. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00123-1 · Cited by 60
Treatment of beta amyloid 1–42 (Aβ1–42)-induced basal forebrain cholinergic damage by a non-classical estrogen signaling activator in vivo
Kwakowsky, A., Potapov, K., Kim, S., Peppercorn, K., Tate, W. P., & Ábrahám, I. M. (2016) · Scientific Reports · doi:10.1038/srep21101 · Cited by 59
The beneficial effect of (-)-epigallocatechin-3-gallate in an experimental model of Alzheimer's disease in rat: a behavioral analysis.
Rasoolijazi, H., Joghataie, M. T., Roghani, M., & Nobakht, M. (2007) · PubMed · Cited by 58
Carbon dots sensitized lanthanide infinite coordination polymer nanoparticles: Towards ratiometric fluorescent sensing of cerebrospinal Aβ monomer as a biomarker for Alzheimer’s disease
Liu, C., Lu, D., You, X., Shi, G., Deng, J., & Zhou, T. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.01.021 · Cited by 58
The Role of Mitochondrial Impairment in Alzheimer´s Disease Neurodegeneration: The Tau Connection
Quntanilla, R. A., & Tapia-Monsalves, C. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200525020259 · Cited by 59
The Antioxidant Vitamins C and E
Packer, L. (2003) · AOCS Publishing eBooks · doi:10.4324/9780429270710 · Cited by 59
Roles of Cholesterol and Lipids in the Etiopathogenesis ofAlzheimer′s Disease
Rojo, L. E., Sjöberg-Herrera, M. K., Hernández, P., Zambrano, C. A., & Maccioni, R. B. (2006) · BioMed Research International · doi:10.1155/jbb/2006/73976 · Cited by 57
Ligand‐Based and Structure‐Based Investigation for Alzheimer’s Disease from Traditional Chinese Medicine
Liao, K., Chen, K., Lee, W., Sun, M.-F., Lee, C.-C., & Chen, C. Y. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/364819 · Cited by 57
Alzheimer’s disease, apolipoprotein E and hormone replacement therapy
Depypere, H. T., Vierin, A., Weyers, S., & Sieben, A. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.09.009 · Cited by 60
Alzheimer´s Disease in the Perspective of Neuroimmunology
Maccioni, R. B., González, A., Andrade, V., Cortés, N., Tapia, J. P., & Guzmán‐Martínez, L. (2018) · The Open Neurology Journal · doi:10.2174/1874205x01812010050 · Cited by 58
The Role of Serotonin Receptors in Alzheimer’s disease
Butzlaff, M., & Ponimaskin, E. G. (2016) · Russian Agency for Digital Standardization · doi:10.20388/omp2016.001.0018 · Cited by 56
Molecular mechanisms of developmental pathways in neurological disorders: a pharmacological and therapeutic review
Jha, N. K., Chen, W., Kumar, S., Dubey, R., Tsai, L.-W., Kar, R., Jha, S. K., Gupta, P. K., Sharma, A., Gundamaraju, R., et al. (2022) · Open Biology · doi:10.1098/rsob.210289 · Cited by 62
Mechanisms of Tau Self-Aggregation and Neurotoxicity
Farias, G. A., Cornejo, A., Jimenez, J., Guzmán, L., & Maccioni, R. B. (2011) · Current Alzheimer Research · doi:10.2174/156720511796717258 · Cited by 55
Epidemiology, Assessment, and Treatment of Dementia
Nowrangi, M. A., Rao, V., & Lyketsos, C. G. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.02.004 · Cited by 58
Lithium Treatment Decreases Activities of Tau Kinases in a Murine Model of Senescence
Tajes, M., Cuesta, J., Folch, J., Ferrer, I., Caballero, B., Smith, M. A., Casadesús, G., Camins, A., & Pallàs, M. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181776293 · Cited by 56
Promotion of cellular NAD+ anabolism: Therapeutic potential for oxidative stress in ageing and alzheimer’s disease
Braidy, N., Guillemin, G. J., & Grant, R. (2008) · Neurotoxicity Research · doi:10.1007/bf03033501 · Cited by 55
Visual Features in Alzheimer’s Disease: From Basic Mechanisms to Clinical Overview
Cerquera-Jaramillo, M. A., Nava-Mesa, M. O., González-Reyes, R. E., Téllez-Conti, C., & de‐la‐Torre, A. (2018) · Neural Plasticity · doi:10.1155/2018/2941783 · Cited by 61
Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer’s disease
Carola Otth, L., Mendoza‐Naranjo, A., Mujica, L., Zambrano, Á., Concha, I. I., & Maccioni, R. B. (2003) · Neuroreport · doi:10.1097/00001756-200312190-00023 · Cited by 54
Can Nutraceuticals Prevent Alzheimer's Disease? Potential Therapeutic Role of a Formulation Containing Shilajit and Complex B Vitamins
Carrasco‐Gallardo, C., Farias, G. A., Fuentes, P., Crespo, F., & Maccioni, R. B. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.010 · Cited by 52
Inhibitors of glycogen synthase kinase-3: future therapy for unmet medical needs?
Dorronsoro, I., Castro, A., & Martı́nez, A. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.10.1527 · Cited by 53
Magnoflorine improves cognitive deficits and pathology of Alzheimer's disease via inhibiting of JNK signaling pathway
Zhong, L., Qin, Y., Liu, M., Sun, J., Tang, H., Zeng, Y., Zhang, J., Wang, W., Liang, G., & Zhao, X. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154714 · Cited by 53
Importance of research on peptidylarginine deiminase and citrullinated proteins in age‐related disease
Ishigami, A., & Maruyama, N. (2010) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2010.00593.x · Cited by 52
A novel anti-Alzheimer's disease drug, ladostigil
Weinreb, O., Amit, T., Bar‐Am, O., & Youdim, M. B. H. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-386467-3.00010-8 · Cited by 54
The aging brain: less neurons could be better
Rutten, B. P. F. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(03)00002-2 · Cited by 52
A review on traditional Chinese medicine natural products and acupuncture intervention for Alzheimer’s disease based on the neuroinflammatory
Chen, Z., Wang, X., Du, S., Liu, Q., Xu, Z., Guo, Y., & Lin, X. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00900-6 · Cited by 59
Neurodegenerative diseases: exercising towards neurogenesis and neuroregeneration
Ang, E. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00025 · Cited by 51
Common Transcriptional Signatures in Brain Tissue from Patients with HIV-Associated Neurocognitive Disorders, Alzheimer’s Disease, and Multiple Sclerosis
Borjabad, A., & Volsky, D. J. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9409-5 · Cited by 51
Nitric Oxide Homeostasis in Neurodegenerative Diseases
Hannibal, L. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150921101250 · Cited by 53
The Natural Product Curcumin as a Potential Coadjuvant in Alzheimer's Treatment
Morales, I., Cerda-Troncoso, C., Andrade, V., & Maccioni, R. B. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170354 · Cited by 51
In vitro Neurogenesis from Neural Progenitor Cells Isolated from the Hippocampus Region of the Brain of Adult Rats Exposed to Ethanol during Early Development through Their Alcohol-Drinking Mothers
Singh, A. K., Gupta, S., Jiang, Y., Younus, M., & Ramzan, M. (2009) · Alcohol and Alcoholism · doi:10.1093/alcalc/agn109 · Cited by 53
Polygonati Rhizoma: A review on the extraction, purification, structural characterization, biosynthesis of the main secondary metabolites and anti-aging effects
Pan, M., Wu, Y., Sun, C., Ma, H., Ye, X., & Li, X. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118002 · Cited by 50
The development of effective biomarkers for Alzheimer's disease: a review
Henry, M. S., Passmore, A. P., Todd, S., McGuinness, B., Craig, D., & Johnston, J. A. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3829 · Cited by 51
Antiapoptotic Drugs: A Therapautic Strategy for the Prevention of Neurodegenerative Diseases
Sureda, F. X., Junyent, F., Verdaguer, E., Auladell, C., Pelegrí, C., Vilaplana, J., Folch, J., Canudas, A. M., Zárate, C. B., Pallàs, M., et al. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795049732 · Cited by 49
RETRACTED: A shared comparison of diabetes mellitus and neurodegenerative disorders
Morsi, M., Maher, A., Aboelmagd, O., Johar, D., & Bernstein, L. H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26261 · Cited by 52
Retracted
Cu II Binding to Various Forms of Amyloid‐β Peptides: Are They Friends or Foes?
Borghesani, V., Aliès, B., & Hureau, C. (2017) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.201700776 · Cited by 50
The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer’s disease
Rubin, L. H., Sundermann, E. E., & Moore, D. J. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-018-0702-9 · Cited by 53
A Chemical Genetic Approach for the Identifi cation of Direct Substrates of Protein Kinases
Shah, K., & Shokat, K. M. (2003) · Humana Press eBooks · doi:10.1385/1-59259-397-6:253 · Cited by 49
Behavioral and neuropsychiatric disorders in Alzheimer's disease
Cortés, N., Andrade, V., & Maccioni, R. B. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180005 · Cited by 57
Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β‐amyloid in ageing and Alzheimer's disease
Weinreb, O., Amit, T., Bar‐Am, O., & Youdim, M. B. H. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13318 · Cited by 48
Microtransplantation of functional receptors and channels from the Alzheimer's brain to frog oocytes
Miledi, R., Dueñas, Z., Martínez‐Torres, A., Kawas, C. H., & Eusebi, F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308224100 · Cited by 48
Interleukin-3 prevents neuronal death induced by amyloid peptide
Zambrano, Á., Carola Otth, L., Mujica, L., Concha, I. I., & Maccioni, R. B. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-82 · Cited by 47
GSK-3 Phosphorylates δ-Catenin and Negatively Regulates Its Stability via Ubiquitination/Proteosome-mediated Proteolysis
Oh, M., Kim, H., Yang, I., Park, J.-H., Cong, W., Baek, M., Bareiss, S. K., Ki, H., Lu, Q., No, J., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.002659 · Cited by 46
Production of nerve growth factor by β‐amyloid‐stimulated astrocytes induces p75NTR‐dependent tau hyperphosphorylation in cultured hippocampal neurons
Sáez, E. T., Pehar, M., Vargas, M. R., Barbeito, L., & Maccioni, R. B. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20996 · Cited by 48
Curcumin Targeted, Polymalic Acid-Based MRI Contrast Agent for the Detection of Aβ Plaques in Alzheimer's Disease
Patil, R., Gangalum, P. R., Wagner, S. R., Portilla‐Arias, J., Ding, H., Rekechenetskiy, A., Konda, B. M., Inoue, S., Black, K. L., Ljubimova, J. Y., et al. (2015) · Macromolecular Bioscience · doi:10.1002/mabi.201500062 · Cited by 46
Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting
Gervaise-Henry, C., Watfa, G., Albuisson, É., Kolodziej, A., Dousset, B., Olivier, J. L., Jonveaux, T., & Malaplate, C. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160865 · Cited by 46
Possible prophylactic anti-excitotoxic and anti-oxidant effects of virgin coconut oil on aluminium chloride-induced Alzheimer’s in rat models
Alghamdi, B. S. A. (2018) · Journal of Integrative Neuroscience · doi:10.3233/jin-180089 · Cited by 49
Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators
Maurya, S. K., Mishra, J., Abbas, S., & Bandyopadhyay, S. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9061-6 · Cited by 46
Polyethylene glycol treatment after traumatic brain injury reduces β‐amyloid precursor protein accumulation in degenerating axons
Koob, A. O., & Borgens, R. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20837 · Cited by 43
Cannabinoids in neurodegeneration and neuroprotection
Fernández‐Ruíz, J., González, S. R., Romero, J., & Ramos, J. A. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7358-x_5 · Cited by 46
Mutated tau, amyloid and neuroinflammation in Alzheimer disease—A brief review
Hung, A., Liang, Y., Chow, T. C. H., Tang, H. C., Wu, S. L. Y., Wai, M., & Yew, D. T. W. (2016) · Progress in Histochemistry and Cytochemistry · doi:10.1016/j.proghi.2016.01.001 · Cited by 47
Medicine–food herb: Angelica sinensis , a potential therapeutic hope for Alzheimer's disease and related complications
Long, Y., Li, D., Yu, S., Shi, A., Deng, J., Wen, J., Li, X., Ma, Y., Yu-lu, Z., Liu, S., et al. (2022) · Food & Function · doi:10.1039/d2fo01287a · Cited by 43
Effects of Natural Flavones and Flavonols on the Kinase Activity of Cdk5
Zapata‐Torres, G., Opazo, F., Salgado, J. C., Muñoz, J. P., Krautwurst, H., Mascayano, C., Sepúlveda‐Boza, S., Maccioni, R. B., & Cassels, B. K. (2004) · Journal of Natural Products · doi:10.1021/np034011s · Cited by 44
Eosinophil-induced neurotoxicity: The role of eosinophil cationic protein/RNase 3
Navarro, S., Boix, E., Cuchillo, C. M., & Nogués, M. V. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.06.012 · Cited by 43
Link Between Chronic Bacterial Inflammation and Alzheimer Disease
Bibi, F., Yasir, M., Sohrab, S. S., Azhar, E. I., Al-Qahtani, M., Abuzenadah, A. M., Kamal, M. A., & Naseer, M. I. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666140917115741 · Cited by 43
Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration
Cortés, N., Andrade, V., Guzmán‐Martínez, L., Estrella, M., & Maccioni, R. B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040956 · Cited by 43
Role of pituitary adenylate cyclase-activating polypeptide (PACAP) in the action of ginsenoside Rh2 against beta-amyloid-induced inhibition of rat brain astrocytes
Shieh, P.-C., Tsao, C.-W., Li, J.-S., Wu, H., Wen, Y.-J., Kou, D., & Cheng, J. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.12.032 · Cited by 43
Analysis of Oestrogen Regulation of Alpha-, Beta- and Gamma-Secretase Gene and Protein Expression in Cultured Human Neuronal and Glial Cells
Csöregh, L., Sundqvist, J., Andersson, E., & Fried, G. (2010) · Neurodegenerative Diseases · doi:10.1159/000282279 · Cited by 43
Biomarkers for Alzheimer's disease
Pauwels, E. K. J., Volterani, D., & Marlani, G. (2009) · Drug News & Perspectives · doi:10.1358/dnp.2009.22.3.1354128 · Cited by 44
Critical Issues for Successful Immunotherapy in Alzheimers Disease: Development of Biomarkers and Methods for Early Detection and Intervention
Tarawneh, R. M., & Holtzman, D. M. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787847324 · Cited by 43
Aberrant Neuronal Cell Cycle Re-Entry: The Pathological Confluence of Alzheimer’s Disease and Brain Insulin Resistance, and Its Relation to Cancer
Köseoğlu, M. M., Norambuena, A., Sharlow, E. R., Lazo, J. S., & Bloom, G. S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180874 · Cited by 41
Implication of the transcription factor E2F-1 in the modulation of neuronal apoptosis
Verdaguer, E., Susana, G. D. A., Allgaier, C., Pallàs, M., & Camins, A. (2006) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2006.11.001 · Cited by 43
Does Impairment of Adult Neurogenesis Contribute to Pathophysiology of Alzheimer's Disease? A Still Open Question
Puma, D. D. L., Piacentini, R., & Grassi, C. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.578211 · Cited by 46
Cyclin C expression is involved in the pathogenesis of Alzheimer's disease
Ueberham, U. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00132-x · Cited by 40
Natural antioxidants in prevention and management of Alzheimer s disease
Zhao, B. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e419 · Cited by 41
Mitochondrial Molecular Abnormalities Revealed by Proteomic Analysis of Hippocampal Organelles of Mice Triple Transgenic for Alzheimer Disease
Yu, H., Lin, X., Wang, D., Zhang, Z., Guo, Y. M., Ren, X., Xu, B., Yuan, J., Liu, J., Spencer, P. S., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00074 · Cited by 40
Metallostasis and amyloid β-degrading enzymes
Grasso, G., Giuffrida, M. L., & Rizzarelli, E. (2012) · Metallomics · doi:10.1039/c2mt20105d · Cited by 41
Glucose-6-phosphate dehydrogenase deficiency and Alzheimer’s disease: Partners in crime? The hypothesis
Ulusu, N. N. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2015.05.006 · Cited by 40
Multifunctional peptide-assembled micelles for simultaneously reducing amyloid-β and reactive oxygen species
Li, L., Zou, Z., Liu, J., Xu, Z., Fu, Y., Tian, Y., & Zhang, W. (2021) · Chemical Science · doi:10.1039/d1sc00153a · Cited by 38
Expression of mutant N-terminal huntingtin fragment (htt552-100Q) in astrocytes suppresses the secretion of BDNF.
Wang, L.-H., Lin, F., Wang, J., Wu, J.-C., Han, R., Zhu, L.-J., DiFiglia, M., & Qin, Z.-H. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.077 · Cited by 37
Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?
Yan, L., Xiao, M., Chen, R., & Cai, Z. (2013) · PubMed · Cited by 39

Authors: Maccioni, R. B., Muñoz, J. P., & Barbeito, L.
Affiliations: University of Chile (CL)
Instituto de Investigaciones Biológicas Clemente Estable (UY)
Corresponding author: Maccioni, Ricardo B
ORCID: Maccioni, Ricardo B
Muñoz, Juan P
Barbeito, Luis
Venue: Archives of Medical Research
Publisher: Elsevier BV
Published: 2001-09
Volume: 32
Issue: 5
Pages: 367-381
ISSN: 0066-6769 (ISSN-L)
0188-4409
DOI: 10.1016/s0188-4409(01)00316-2
OpenAlex: W1985122965
Cited by: 474
References: 150
Citations by year: 2026: 8 · 2025: 12 · 2024: 24 · 2023: 8 · 2022: 13 · 2021: 14 · 2020: 17 · 2019: 19 · 2018: 20 · 2017: 28 · 2016: 17 · 2015: 17 · 2014: 19 · 2013: 22 · 2012: 30
FWCI: 2.49
Type: journal article
Language: en
Open access: green
americanae.aecid.es
Licence: other-oa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Archives of Medical Research (publishedVersion)
PubMed (publishedVersion)
Americanae (AECID Library) (submittedVersion, other-oa)
LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, neurodegeneration, amyloid plaques, neurofibrillary tangles, amyloid-beta, amyloid precursor protein, tau protein, tau hyperphosphorylation, cyclin-dependent kinase 5, GSK3β, oxidative stress, neuronal cell death, neuroprotective factors, estrogen, antioxidants, protein kinase inhibitors, antisense oligonucleotides, dementia
MeSH terms: Adult, Aged, alpha-Macroglobulins, Alzheimer Disease, Amino Acid Sequence, Apolipoproteins E, Astrocytes, Calcium, Estrogens, Humans, Membrane Proteins, Memory Disorders, Middle Aged, Molecular Sequence Data, Nerve Tissue Proteins, Neurons, Neurotoxins, Nitric Oxide, Parkinson Disease, Protein Processing, Post-Translational, Signal Transduction, Motor Neuron Disease, Amyloid beta-Protein Precursor, Neurofibrillary Tangles, tau Proteins, Cell Death, Age of Onset, Oxidative Stress, Neurodegenerative Diseases, Caspases, Presenilin-1, Presenilin-2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The molecular bases of Alzheimer’s disease and other neurodegenerative disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks